Physician profile
Jordan Silver
NPI 1336536705
$474.59
in general payments reported to CMS, 2019-2025
12 companies · $20.06 in 2025
The $20.06 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2021: $29.03 · 2022: $48.85 · 2023: $106 · 2024: $94.73 · 2025: $20.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $220.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $102.42 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $98.78 | 2019-2024 | Dificid, Zerbaxa, Recarbrio |
| Janssen Pharmaceuticals, INC | $61.48 | 2019-2024 | Xarelto |
| Portola Pharmaceuticals, LLC | $41.56 | 2019 | |
| Philips North America LLC | $37.86 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $27.70 | 2019-2024 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $25.64 | 2019 | |
| Viatris Specialty LLC | $20.06 | 2025 | Yupelri |
| Mylan Specialty L.P. | $16.29 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.37 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.00 | 2019 | |
| Melinta Therapeutics, LLC | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Silver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.